Amanda Leiter
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Prostate Cancer Treatment and Research
- Lung Cancer Diagnosis and Treatment
- Lung Cancer Treatments and Mutations
Papers in
-
- Lung Cancer Diagnosis and Treatment 4
- Prostate Cancer Treatment and Research 3
- Advanced Breast Cancer Therapies 3
- Oncology 12
- Cancer Immunotherapy and Biomarkers 8
- Co-authors
- Juan P. Wisnivesky (5 shared papers)Rajwanth Veluswamy (2 shared papers)Matthew D. Galsky (16 shared papers)H. Phillip Koeffler (4 shared papers)William Oh (13 shared papers)Emily J. Gallagher (22 shared papers)James O’Kelly (2 shared papers)Michael A. Diefenbach (2 shared papers)
- Journals
- Journal of Clinical Oncology (7 papers)PLoS ONE (2 papers)Oncogene (2 papers)Hormones and Cancer (1 paper)JCO Clinical Cancer Informatics (1 paper)
- Partner nations
- United StatesAustraliaIndia
In The Last Decade
Amanda Leiter
41 papers receiving 1.5k citations
Amanda Leiter's Hit Papers
Peers
Comparison fields: 5 of 132
- Cancer Research 225
- Pulmonary and Respiratory Medicine 319
- Oncology 272
- Sensory Systems 50
- Toxicology 22
Countries citing papers authored by Amanda Leiter
This map shows the geographic impact of Amanda Leiter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amanda Leiter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amanda Leiter more than expected).
Fields of papers citing papers by Amanda Leiter
This network shows the impact of papers produced by Amanda Leiter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amanda Leiter. The network helps show where Amanda Leiter may publish in the future.
Co-authors
The 25 scholars most cited alongside Amanda Leiter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The global burden of lung cancer: current status and future trends Hit paper breakdown → | 2023 | 759 |
| 2 | 2009 | 153 | |
| 3 | 2012 | 95 | |
| 4 | 2015 | 71 | |
| 5 | 2015 | 59 | |
| 6 | 2011 | 40 | |
| 7 | 2012 | 35 | |
| 8 | 2014 | 31 | |
| 9 | 2014 | 30 | |
| 10 | 2017 | 22 | |
| 11 | 2019 | 22 | |
| 12 | 2021 | 22 | |
| 13 | 2021 | 20 | |
| 14 | 2019 | 19 | |
| 15 | 2022 | 18 | |
| 16 | 2020 | 12 | |
| 17 | 2020 | 11 | |
| 18 | 2020 | 10 | |
| 19 | 2020 | 9 | |
| 20 | 2022 | 8 |
About Amanda Leiter
Amanda Leiter is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Cancer Research and Molecular Biology, having authored 47 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (8 papers), Bladder and Urothelial Cancer Treatments (4 papers), Multiple and Secondary Primary Cancers (4 papers), Lung Cancer Diagnosis and Treatment (4 papers), Prostate Cancer Treatment and Research (3 papers), Pituitary Gland Disorders and Treatments (3 papers), Advanced Breast Cancer Therapies (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). The work is most often cited by research in Cancer Research (225 citations), Pulmonary and Respiratory Medicine (319 citations), Oncology (272 citations), Sensory Systems (50 citations) and Toxicology (22 citations). Amanda Leiter has collaborated with scholars based in United States, Australia and India. Frequent co-authors include Juan P. Wisnivesky, Rajwanth Veluswamy, Matthew D. Galsky, H. Phillip Koeffler, William Oh, Emily J. Gallagher, James O’Kelly, Michael A. Diefenbach, Daning Lu and Gabriela B. Iwanski. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE, Oncogene, Hormones and Cancer and JCO Clinical Cancer Informatics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.